The state Duma Committee on health approved the amendment on the right of the government to delay mandatory labelling for a number of drugs for 3-6 months, said a member of the Committee, Boris Mendelevich, writes Prime.
From 1 July 2020, Russia has introduced compulsory labelling of all medicines. The sale of unmarked medicines received into circulation until July 1, 2020, will be allowed until the expiration of their shelf life. However, the deputies will offer Healthcare not penalize pharmaceutical companies who, for objective reasons, were not ready for the introduction of labelling from 1 July.
“In the end, it was decided that the particularly vulnerable types of drugs, given the delay to October 1, and for some others – until December 31,” said Mendelevich.
“Marking is a large-scale work, which involves many organizations and technologies. In pandemic, the process slowed down. So personally, I advocated that those organizations who did not label their drugs, were able to complete this process within 3-4 months. Otherwise how to be people, for example, with rare diseases for which drugs are released within a matter of numbers,” — said the Deputy.